SCHEMBL1010796

SCHEMBL1010796

CCN1C(=O)C=C(O)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
BLM P54132 2/20 0.46
GMNN O75496 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
THPO P40225 1/20 0.46
PMP22 Q01453 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MGLL Q99685 1/20 0.46
F2 P00734 1/20 0.40
ELANE P08246 1/20 0.40
CTSG P08311 1/20 0.40
CTRC Q99895 1/20 0.40
CYP1B1 Q16678 1/20 0.34
POLB P06746 2/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
XIAP P98170 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4011867 0.74 ALDH1A1 (0.48) ALDH1A1BLMGMNNLMNAMAPT
SCHEMBL20216186 0.74 ALDH1A1 (0.48) ALDH1A1BLMGMNNLMNAMAPT
SCHEMBL14136363 0.73 ALDH1A1 (0.46) ALDH1A1BLMGMNNLMNAMAPT
SCHEMBL988699 0.73 ALDH1A1 (0.46) ALDH1A1BLMGMNNLMNAMAPT
SCHEMBL3470129 0.73 RGS4 (0.53) ALDH1A1BLMGMNNLMNAMAPT
SCHEMBL27607300 0.72 POLB (0.42) ALDH1A1BLMGMNNLMNAMAPT
SCHEMBL6809868 0.71 RGS4 (0.48) ALDH1A1BLMGMNNLMNAMAPT
SCHEMBL3691142 0.71 ALDH1A1 (0.36) ALDH1A1BLMGMNNLMNAMAPT
SCHEMBL4741750 0.71 MGLL (0.44) ALDH1A1BLMGMNNLMNAMAPT
SCHEMBL25197755 0.71 GMNN (0.40) ALDH1A1BLMGMNNLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110117009-A1 DRUG CONJUGATES WITH POLYGLYCEROLS FREIE UNIVERSITÄT BERLIN (DE) 2011-05-19 US disclosed
EP-2268315-A1 DRUG CONJUGATES WITH POLYGLYCEROLS Freie Universität Berlin (DE) 2011-01-05 EP disclosed
EP-2216049-A1 Drug conjugates with polyglycerols Freie Universität Berlin (DE) 2010-08-11 EP disclosed
WO-2009121564-A1 DRUG CONJUGATES WITH POLYGLYCEROLS FREIE UNIVERSITÄT BERLIN (DE) 2009-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110117009-A1 DRUG CONJUGATES WITH POLYGLYCEROLS DDOST, STT3A, STT3B ALDH1A1 2528/4885BLM 4256/4885GMNN 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.